COVID-19

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

Check out this infographic breakdown of the company’s first-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

Chairman & CEO Alex Gorsky shares that the company could have the first batches of a COVID-19 vaccine available for emergency-use authorization in early 2021—a substantially accelerated time frame in comparison to the typical vaccine development process.

The funds will be earmarked for assisting the doctors, nurses, midwives and community health workers who are working tirelessly to treat patients around the world during the novel coronavirus pandemic.

Dr. Dongchen Zhou was a practicing cardiologist in Hangzhou, Zhejiang Province, China, when he received a call to help volunteer at a hospital in Wuhan. In February 2020 he began to treat COVID-19 patients—and recounts for us what his journey was like.